The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study
Open accessAbstract
Background—: The bulk of cardiovascular disease risk is not explained by traditional risk factors. Recent advances in mass spectrometry allow the identification and quantification of hundreds of lipid species. Molecular lipid profiling by mass spectrometry may improve cardiovascular risk prediction. Methods and Results—: Lipids were extracted from 685 plasma samples of the prospective population-based Bruneck Study (baseline evaluation in 2000). One hundred thirty-five lipid species from 8 different lipid classes were profiled by shotgun lipidomics with the use of a triple-quadrupole mass spectrometer. Levels of individual species of cholesterol esters (CEs), lysophosphatidylcholines, phosphatidylcholines, phosphatidylethanolamines (PEs), sphingomyelins, and triacylglycerols (TAGs) were associated with cardiovascular disease over a 10-year observation period (2000–2010, 90 incident events). Among the lipid species with the strongest predictive value were TAGs and CEs with a low carbon number and double-bond content, including TAG(54:2) and CE(16:1), as well as PE(36:5) ( P =5.1×10 −7 , 2.2×10 −4 , and 2.5×10 −3 , respectively). Consideration of these 3 lipid species on top of traditional risk factors resulted in improved risk discrimination and classification for cardiovascular disease (cross-validated ΔC index, 0.0210 [95% confidence interval, 0.0010-0.0422]; integrated discrimination improvement, 0.0212 [95% confidence interval, 0.0031-0.0406]; and continuous net reclassification index, 0.398 [95% confidence interval, 0.175-0.619]). A similar shift in the plasma fatty acid composition was associated with cardiovascular disease in the UK Twin Registry (n=1453, 45 cases). Conclusions—: This study applied mass spectrometry-based lipidomics profiling to population-based cohorts and identified molecular lipid signatures for cardiovascular disease. Molecular lipid species constitute promising new biomarkers that outperform the conventional biochemical measurements of lipid classes currently used in clinics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
A new look at the statistical model identification
Akaike, H. (1974) · IEEE Transactions on Automatic Control · doi:10.1109/tac.1974.1100705 · Cited by 51,879
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., Pencina, M. J., & Kattan, M. W. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181c30fb2 · Cited by 5,170
Hierarchical Organization of Modularity in Metabolic Networks
Ravasz, E., Somera, A. L., Mongru, D. A., Oltvai, Z. N., & Barabási, A.-L. (2002) · Science · doi:10.1126/science.1073374 · Cited by 4,224
Algorithms for Minimization Without Derivatives
G., D., & Brent, R. P. (1974) · Mathematics of Computation · doi:10.2307/2005713 · Cited by 2,847
Major lipids, apolipoproteins, and risk of vascular disease
The Emerging Risk Factors Collaboration* (2009) · JAMA · doi:10.1001/jama.2009.1619 · Cited by 2,731
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
Pencina, M. J., D'Agostino, R. B., & Steyerberg, E. W. (2011) · Statistics in Medicine · doi:10.1002/sim.4085 · Cited by 2,453
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Lipidomics reveals a remarkable diversity of lipids in human plasma
Quehenberger, O., Armando, A. M., Brown, A. H., Milne, S. B., Myers, D. S., Merrill, A. H., Bandyopadhyay, S., Jones, K. N., Kelly, S., Shaner, R. L., et al. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m009449 · Cited by 1,341
Chapman, M. J., Ginsberg, H. N., Amarenco, P., Andreotti, F., Borén, J., Catapano, A. L., Descamps, O. S., Fisher, E., Kovanen, P. T., Kuivenhoven, J. A., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr112 · Cited by 1,227
Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism
Cao, H., Gerhold, K., Mayers, J. R., Wiest, M. M., Watkins, S. M., & Hotamisligil, G. S. (2008) · Cell · doi:10.1016/j.cell.2008.07.048 · Cited by 1,139
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Self-citationL1Penalized Estimation in the Cox Proportional Hazards Model
Goeman, J. J. (2010) · Biometrical Journal · doi:10.1002/bimj.200900028 · Cited by 816
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
(2010) · The Lancet · doi:10.1016/s0140-6736(10)60545-4 · Cited by 716
Rhee, E. P., Cheng, S., Larson, M. G., Walford, G. A., Lewis, G. D., McCabe, E., Yang, E., Farrell, L., Fox, C. S., O’Donnell, C. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44442 · Cited by 647
Genome-wide association study identifies multiple loci influencing human serum metabolite levels
Kettunen, J., Tukiainen, T., Sarin, A.-P., Ortega-Alonso, A., Tikkanen, E., Lyytikäinen, L.-P., Kangas, A. J., Soininen, P., Würtz, P., Silander, K., et al. (2012) · Nature Genetics · doi:10.1038/ng.1073 · Cited by 553
Telomere length and risk of incident cancer and cancer mortality
Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., Kronenberg, F., & Kiechl, S. (2010) · JAMA · doi:10.1001/jama.2010.897 · Cited by 484
Self-citationProspective Study on Circulating MicroRNAs and Risk of Myocardial Infarction
Zampetaki, A., Willeit, P., Tilling, L., Drozdov, I., Prokopi, M., Renard, J.-M., Mayr, A., Weger, S., Schett, G., Shah, A., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.03.056 · Cited by 464
Self-citationThe National Survey of Stroke. Clinical findings.
Walker, A., Robins, M., & Weinfeld, F. D. (1981) · PubMed · Cited by 460
Shah, S. H., Kraus, W. E., & Newgard, C. B. (2012) · Circulation · doi:10.1161/circulationaha.111.060368 · Cited by 370
The search for new cardiovascular biomarkers
Gerszten, R. E., & Wang, T. J. (2008) · Nature · doi:10.1038/nature06802 · Cited by 358
Han, X., & Gross, R. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5178 · Cited by 358
Top-Down Lipidomics Reveals Ether Lipid Deficiency in Blood Plasma of Hypertensive Patients
Graessler, J., Schwudke, D., Schwarz, P. E. H., Herzog, R., Shevchenko, A., & Bornstein, S. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006261 · Cited by 323
Shah, S. H., Sun, J.-L., Stevens, R. D., Bain, J. R., Muehlbauer, M. J., Pieper, K. S., Haynes, C., Hauser, E. R., Kraus, W. E., Granger, C. B., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.02.005 · Cited by 314
Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease
Meikle, P. J., Wong, G., Tsorotes, D., Barlow, C. K., Weir, J. M., Christopher, M. J., MacIntosh, G. L., Goudey, B., Stern, L., Kowalczyk, A., et al. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.234096 · Cited by 306
Role of Risk Factors in the Modulation of Tissue Factor Activity and Blood Thrombogenicity
Sambola, A., Osende, J., Hathcock, J., Degen, M., Nemerson, Y., Fuster, V., Crandall, J., & Badimon, J. J. (2003) · Circulation · doi:10.1161/01.cir.0000050621.67499.7d · Cited by 295
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat
CROSET, M., BROSSARD, N., POLETTE, A., & LAGARDE, M. (2000) · Biochemical Journal · doi:10.1042/bj3450061 · Cited by 246
Cohort Profile: TwinsUK and Healthy Ageing Twin Study
Moayyeri, A., Hammond, C. J., Valdes, A. M., & Spector, T. D. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyr207 · Cited by 246
Self-citationSoftware Tools for Analysis of Mass Spectrometric Lipidome Data
Haimi, P., Uphoff, A., Hermansson, M., & Somerharju, P. (2006) · Analytical Chemistry · doi:10.1021/ac061390w · Cited by 229
Comparative Lipidomics Profiling of Human Atherosclerotic Plaques
Stegemann, C., Drozdov, I., Shalhoub, J., Humphries, J., Ladroue, C., Didangelos, A., Baumert, M., Allen, M., Davies, A. H., Monaco, C., et al. (2011) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.959098 · Cited by 209
Self-citationHigh heritability of metabolomic profiles in families burdened with premature cardiovascular disease
Shah, S. H., Hauser, E. R., Bain, J. R., Muehlbauer, M. J., Haynes, C. S., Stevens, R. D., Wenner, B. R., Dowdy, Z. E., Granger, C. B., Ginsburg, G. S., et al. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.11 · Cited by 145
Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Cardiovascular Disease
Kiechl, S. J., Schett, G. A., Schwaiger, J., Seppi, K., Eder, P., Egger, G., Santer, P., Mayr, A., Xu, Q., & Willeit, J. (2007) · Circulation · doi:10.1161/circulationaha.106.686774 · Cited by 119
Self-citationÖhrvall, M., Berglund, L., Salminen, I., Lithell, H., Aro, A., & Vessby, B. O. (1996) · Atherosclerosis · doi:10.1016/s0021-9150(96)05936-9 · Cited by 104
Efficient calculation of accurate masses of isotopic peaks
Rockwood, A. L., & Haimi, P. (2006) · Journal of the American Society for Mass Spectrometry · doi:10.1016/j.jasms.2005.12.001 · Cited by 104
Sun, G., Yang, K., Zhao, Z., Guan, S., Han, X., & Gross, R. W. (2007) · Analytical Chemistry · doi:10.1021/ac070843+ · Cited by 90
Chong, S. C., Fielding, B. A., & Frayn, K. N. (2007) · Proceedings of The Nutrition Society · doi:10.1017/s0029665107005290 · Cited by 74
Metabolomics: Ready for the Prime Time?
Mayr, M. (2008) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.108.808329 · Cited by 72
Self-citationDuivenvoorden, R., Holleboom, A. G., van den Bogaard, B., Nederveen, A. J., de Groot, E., Hutten, B. A., Schimmel, A. W. M., Hovingh, G. K., Kastelein, J. J. P., Kuivenhoven, J. A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.092 · Cited by 61
Gross, R. W., & Han, X. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90970.2008 · Cited by 59
Lipidomics in Diabetes and the Metabolic Syndrome
Gross, R. W., & Han, X. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)33004-8 · Cited by 56
Metabolomics and ischaemic heart disease
Rasmiena, A. A., Ng, T. W., & Meikle, P. J. (2012) · Clinical Science · doi:10.1042/cs20120268 · Cited by 49
Castro‐Perez, J. M., Roddy, T. P., Shah, V., McLaren, D. G., Wang, S.-P., Jensen, K., Vreeken, R. J., Hankemeier, T., Johns, D. G., Previs, S. F., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200480g · Cited by 41
The -omics era: Proteomics and lipidomics in vascular research
Didangelos, A., Stegemann, C., & Mayr, M. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.09.043 · Cited by 40
Self-citationEfficient Calculation of Jackknife Confidence Intervals for Rank Statistics
Newson, R. B. (2006) · Journal of Statistical Software · doi:10.18637/jss.v015.i01 · Cited by 28
Miller, C. D., Thomas, M. J., Hiestand, B. C., Samuel, M. P., Wilson, M. D., Sawyer, J. K., & Rudel, L. L. (2012) · Academic Emergency Medicine · doi:10.1111/j.1553-2712.2012.01378.x · Cited by 22
Harrell, F., Jr. (1996) · doi:10.1002/(sici)1097-0258(19960229)15:4<361::aid-sim168>3.0.co;2-4
Cited by
Cardioprotection and lifespan extension by the natural polyamine spermidine
Eisenberg, T., Abdellatif, M., Schroeder, S., Primessnig, U., Stekovic, S., Pendl, T., Harger, A., Schipke, J., Zimmermann, A., Schmidt, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4222 · Cited by 1,168
Self-citationAn Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
Law, S.-H., Chan, M.-L., Marathe, G. K., Parveen, F., Chen, C.-H., & Ke, L.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051149 · Cited by 817
Würtz, P., Havulinna, A. S., Soininen, P., Tynkkynen, T., Prieto-Merino, D., Tillin, T., Ghorbani, A., Artati, A., Wang, Q., Tiainen, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013116 · Cited by 677
Inflammatory processes in cardiovascular disease: a route to targeted therapies
Ruparelia, N., Chai, J. T., Fisher, E. A., & Choudhury, R. P. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.185 · Cited by 477
Alterations in the gut microbiome and metabolism with coronary artery disease severity
Liu, H., Chen, X., Hu, X., Niu, H., Tian, R., Wang, H., Pang, H., Jiang, L., Qiu, B., Chen, X., et al. (2019) · Microbiome · doi:10.1186/s40168-019-0683-9 · Cited by 372
Metadata
- Authors
- Stegemann, C., Pechlaner, R., Willeit, P., Langley, S. R., Mangino, M., Mayr, U., Menni, C., Moayyeri, A., Santer, P., Rungger, G., Spector, T. D., Willeit, J., Kiechl, S., & Mayr, M.
- Venue
- Circulation
- Published
- 2014-05-06
- Volume
- 129
- Issue
- 18
- Pages
- 1821-1831
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2035598079
- Cited by
- 564
- References
- 54
- FWCI
- 13.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.